Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 8R5CM46UIO

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT B-lymphocyte antigen CD20 binding agent Other PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Follicular 2 D008224 ClinicalTrials
Lymphoma 1 D008223 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298084
FDA SRS 8R5CM46UIO